WARYFOOL
No Result
View All Result
  • Home
No Result
View All Result
WARYFOOL
No Result
View All Result
Home Money

Xenon Pharmaceuticals Announces Conference Call And Webcast To Discuss Year-End 2020 Financial Results

February 23, 2021
Reading Time:2min read

BURNABY, British Columbia, Feb. 23, 2021 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced it will report its 2020 financial and operating results after the close of U.S. financial markets on Monday, March 1, 2021:

  • Xenon management will host a conference call and live audio webcast at 4:30 pm Eastern Time (1:30 pm Pacific Time) on Monday, March 1, 2021 to discuss the year-end results and to provide a corporate update. The webcast will be broadcast live on the Investors section of the Xenon website. To participate in the call, please dial (855) 779-9075, or (631) 485-4866 for international callers, and provide conference ID number 6061326.

In addition, Xenon will participate in a fireside discussion at the following upcoming virtual investor conference, which will be webcast live on the Investors section of the Xenon website:

  • SVB Leerink 10th Annual Global Healthcare Conference at 10:00 am Eastern Time on Wednesday, February 24, 2021.

The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the “Investors” section of Xenon’s website at www.xenon-pharma.com. When available, webcasts will be posted for replay following the event.

About Xenon Pharmaceuticals Inc.

We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:Jodi RegtsXenon Pharmaceuticals Inc.Phone: 604.484.3353Email: [email protected]

————————

Originally published at https://www.thestreet.com/press-releases/xenon-pharmaceuticals-announces-conference-call-and-webcast-to-discuss-year-end-2020-financial-results-15575104 on February 23, 2021 12:45 pm.

ShareTweetPin

Related Posts

Money

Teladoc Lower After Posting Wider-Than-Expected Loss

February 24, 2021
Disney and the NFL are reportedly sparring over a proposed TV deal that would cost the ABC and ESPN owner nearly $4 billion every year (DIS)
Money

Disney and the NFL are reportedly sparring over a proposed TV deal that would cost the ABC and ESPN owner nearly $4 billion every year (DIS)

February 24, 2021
Dow Jones Futures: Qualcomm Near Buy Point In Tight Stock Market Rally; Apple Looks Tired
Money

Stock Market Rallies On Dovish Fed; Is The Pullback Really Over?

February 24, 2021
30 of Coursera's most popular courses right now, offered by Yale, UPenn, Johns Hopkins, Google, IBM, and more
Money

Coursera Plus grants unlimited access to almost all of the site's online courses for $399 a year, and can be a great option if you want multiple professional certificates

February 24, 2021
Money

Martinrea International Inc. To Announce Fourth Quarter And Full-Year Results On March 4, 2021

February 24, 2021
Money

Interpace Biosciences Announces Acceptance For Trading On The OTCQX

February 24, 2021

All your financial news in one place.

Recent Posts

  • Teladoc Lower After Posting Wider-Than-Expected Loss
  • Disney and the NFL are reportedly sparring over a proposed TV deal that would cost the ABC and ESPN owner nearly $4 billion every year (DIS)
  • Stock Market Rallies On Dovish Fed; Is The Pullback Really Over?

© 2020 WARYFOOL.

No Result
View All Result

© 2020 WARYFOOL.